Literature DB >> 25539066

The lack of consensus in management of malignant struma ovarii.

Beatriz González Aguilera1, Raquel Guerrero Vázquez, Noelia Gros Herguido, Felicia Sánchez Gallego, Elena Navarro González.   

Abstract

Struma ovarii is a rare variant of teratoma characterized by the presence of thyroid tissue in more than 50%. Malignant transformation is rare (less than 5%) and the criteria to classify this condition have changed over time. Nowadays it must fulfill the histological categories of differentiated thyroid carcinoma. Its treatment is controversial and there is no unanimous management. We present three cases of women with malignant struma ovarii, diagnosed by the surgical specimen.

Entities:  

Keywords:  Management; struma ovarii; thyroid

Mesh:

Substances:

Year:  2014        PMID: 25539066     DOI: 10.3109/09513590.2014.995616

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  7 in total

1.  Malignant Struma Ovarii with Concurrent Thyroid Cancer: Outcomes during and after Pregnancy.

Authors:  Sara Donato; Helder Simões; Valeriano Leite
Journal:  Eur Thyroid J       Date:  2021-01-27

2.  Malignant Struma Ovarii Τreated With Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).

Authors:  Miklos Acs; Sebastian Häusler; Hamid-Reza Lighvani; Jozef Zustin; Pompiliu Piso
Journal:  In Vivo       Date:  2021 Nov-Dec       Impact factor: 2.155

3.  Rare Clinical Entity: Metastatic malignant struma ovarii diagnosed during pregnancy - Lessons for management.

Authors:  Corey J Lager; Ronald J Koenig; Richard W Lieberman; Anca M Avram
Journal:  Clin Diabetes Endocrinol       Date:  2018-06-19

4.  Clinical characteristics and survival outcomes of malignant struma ovarii confined to the ovary.

Authors:  Sijian Li; Tengyu Yang; Yang Xiang; Xiaoyan Li; Limeng Zhang; Shan Deng
Journal:  BMC Cancer       Date:  2021-04-09       Impact factor: 4.430

5.  Survival Outcomes and Prognostic Predictors in Patients With Malignant Struma Ovarii.

Authors:  Sijian Li; Shujun Kong; Xiaoxue Wang; Xinyue Zhang; Min Yin; Jiaxin Yang
Journal:  Front Med (Lausanne)       Date:  2021-12-23

6.  Management of malignant struma ovarii: is aggressive therapy justified? Case report and literature review.

Authors:  Letiția Leuștean; Maria-Christina Ungureanu; Cristina Preda; Stefana Catalina Bilha; Florin Obrocea; Radu Dănilă; Laura Stătescu; Delia Gabriela Apostol Ciobanu
Journal:  Thyroid Res       Date:  2022-08-11

7.  Papillary Thyroid Cancer in a Struma Ovarii in a 17-Year-Old Nulliparous Patient: A case Report.

Authors:  Agnieszka Gonet; Rafał Ślusarczyk; Danuta Gąsior-Perczak; Artur Kowalik; Janusz Kopczyński; Aldona Kowalska
Journal:  Diagnostics (Basel)       Date:  2020-01-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.